Immediate Impact

11 by Nobel laureates 8 from Science/Nature 50 standout
Sub-graph 1 of 24

Citing Papers

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
2023 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
8 intermediate papers

Works of Michael A. McVoy being referenced

Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans
2017
Cytomegalovirus Vaccines
2013
and 8 more

Author Peers

Author Last Decade Papers Cites
Michael A. McVoy 1869 395 470 94 2.2k
Thomas Mertens 1342 272 235 72 1.9k
Lucy Rasmussen 2123 548 290 48 2.4k
Detlef Michel 1760 304 258 64 2.5k
Richard C. Gehrz 1135 318 274 51 1.6k
Derrick J. Dargan 1981 608 244 35 2.2k
Richard J. Stanton 2020 484 403 78 3.0k
Paola Dal Monte 1354 263 657 66 1.7k
Emma Poole 1899 435 334 61 2.5k
Stephen St. Jeor 910 228 795 60 2.1k
Corinna La Rosa 1232 182 325 53 1.6k

All Works

Loading papers...

Rankless by CCL
2026